Abstract Immunotherapy holds great promise for treatment of infectious and malignant diseases and might help to prevent the occurrence and recurrence of cancer. We produced a plant-derived tumor-associated colorectal cancer antigen EpCAM (pGA733) at high yields using two modern plant expression systems. The full antigenic domain of EpCAM was eYciently puriWed to conWrm its antigenic and immunogenic properties as compared to those of the antigen expressed in the baculovirus system (bGA733). Recombinant plant-derived antigen induced a humoral immune response in BALB/c mice. Sera from those mice eYciently inhibited the growth of SW948 colorectal carcinoma cells xenografted in nude mice, as compared to the EpCAM-speciWc mAb CO17-1A. Our results support the feasibility of producing anti-cancer recombinant vaccines using plant expression systems.
Introduction
The concept of cancer vaccination as a preventive measure is of increasing interest to oncology in view of advances in modern molecular biology and biotechnology [7, 14, 15] . Several anti-cancer vaccines for the treatment of minimal residual disease are currently in human clinical trials [6, 21] . The T-and B-cell immune responses against tumorassociated antigens (TAA) could lead to eYcient elimination of tumor cells without harming the surrounding normal tissue, as well as help to generate long-lasting immunological memory against tumor recurrences, as already shown in humans and animals [8] . There is also strong evidence supporting the use of recombinant antigen vaccines, either alone, or in combination with hormonal, chemotherapeutic and monoclonal antibody approaches, to treat colorectal cancer [1, 5, 19, 22, 26] .
The use of plant biotechnology to produce pharmaceutical and industrial proteins has clear economic scalability and safety advantages as compared to traditional microbial and mammalian production systems [9, 11, 12, 16, 17] . Plants oVer potentially very high expression level of recombinant proteins [10, 11] . However, the main advantage of plant-based expression systems is lack of harmful or even lethal contaminants (viruses, toxins, prions, oncogenes) that might contaminate other production systems [2, [9] [10] [11] [12] . Current eVorts are focused on maximizing expression levels and accumulation of functional plant-produced proteins, preferably in soluble form to facilitate puriWcation [4, 5, 10, 11, 13, 23] . We previously expressed the GA733-2 antigen in planta using a tobacco mosaic virus-based system. Although, mice immunized with the plant-produced product demonstrated an antigen-speciWc immune response, small amounts of plant-derived material precluded complete immunological assessment [26] .
The use of modern transient and stable plant transformation systems now allows the high yield production of GA733-2 TAA in plants. We found that fusion to the endoplasmic reticulum (ER) retaining signal led to increased levels of protein accumulation in plant cells, and an eYcient immuno-aYnity puriWcation procedure yielded EpCAM antigen (pGA733) in suYcient amounts to conWrm its protective immunogenicity in mice. Antigen-speciWc serum antibodies from these mice inhibited tumor cell growth in xenografted nude mice. Our results conWrm the utility of plants in high-yield and inexpensive production of drugs for cancer immunotherapy.
Materials and methods

EpCAM expression cassette design
A DNA fragment of GA733-2 antigen extracellular domain (aa 24-264) [20, 25] was ampliWed by the following primers: F-5Ј-CCATGGCTCAGGAAGAATGTGTCTGT-3Ј and R-5Ј-GTCGACTTTATCATCATCATCAAGATCTTTTAG ACCCTGCATTGAGAATTCA-3Ј, which carry NcoI and BglII sites, respectively. The product was cloned into the pGEMT vector (Promega, Madison, WI, USA), sequenceveriWed, and recloned into plasmid pBIV-1.3Tag (Plant Research International, Wageningen, NL, USA) comprised of the RbcS1 promoter, C-terminal tags (c-myc and His 6 ) and the KDEL retention ER signal. The resulting expression cassette was transferred (AscI/PacI) into the plant binary vector pBIN-Plus (Plant Research International), resulting in plasmid pRB74, which was placed into Agrobacterium tumefaciens strain LBA4404 for stable plant transformation. The GA733 NcoI/SacI fragment from the pBIV-based construct was recloned into the carrier pro-vector plasmid pICH11599 (Icon Genetics, Haale (Saale), Germany) and placed in Agro-strain GV3101 for vacuuminWltration "magnifection" of wild type Swiss chard plants.
Transient and constitutive plant transformation
For rapid production of recombinant antigen, we used the magnifection procedure [10, 11, 13, 18] . Agro-cultures carrying the expression cassette were mixed with cultures carrying pre-manufactured helper plasmids (pICH14011 and pICH17620) (Icon Genetics) and applied to mature (6-8 weeks old) Beta vulgaris var. cicla (Swiss chard) plants. Plant tissues were harvested after 7-10 days and analyzed by Western blot and ELISA. Low-alkaloid Nicotiana tabacum cv. LAMD609 (tobacco) (Oxford Tobacco Research Station, Oxford, NC) was used for leaf explants agro-mediated transformation [5] with pRB74. Independent transgenic lines were selected in medium containing kanamycin (100 mg/l) and used for molecular characterization.
Isolation and puriWcation of plant (p) GA733 protein Plant leaf tissues were collected and processed as described [5, 13] . After centrifugation, supernatants were additionally successively clariWed through a Miracloth (Calbiochem, La Jolla, CA, USA) and a 0.45-m Wlter (Millipore, Bedford, MA, USA). Soluble protein extract was applied on a murine mAb Ab733-immobilized HighTrap column (Amersham, Piscataway, NJ, USA) or puriWed using His 6 and c-myc tags as described [13] . Eluates of recombinant pGA733 protein were combined, dialyzed against PBS buVer and brought to a Wnal concentration 1 mg/ml using Amicon Ultra spin-column with a 10-kDa cut-oV (Millipore). Aliquots were frozen in liquid nitrogen and stored at ¡80°C. For analysis extracts were resolved by SDS-polyacrylamide gel electrophoresis (PAGE) and either stained or transferred to a nitrocellulose membrane (Bio-rad, Hercules, CA, USA), blocked with 5% non-fat milk and incubated with murine c-myc mAb (Calbiochem, San Diego, CA, USA) or mAb Ab733 followed by secondary antimouse Fc-speciWc Ab conjugated to horseradish peroxidase (Sigma, St Louis, MO, USA) diluted 1:10,000. Reactive protein bands were visualized using chemiluminescent substrate for peroxidase (Pierce, Rockford, IL, USA).
Immunological analysis of pGA733 in mice
Eight-week-old female BALB/c mice (Wve per group) were injected with three doses (5 g) of pGA733 in a total volume of 100 l at 2-week intervals. First and second immunizations were given subcutaneously (s.c.) with complete and incomplete Freund's adjuvant (Difco, Detroit, MI, USA), respectively; the third dose was administered interperitoneally (i.p.) in saline. Control groups received 5 g per injection of baculovirus-produced bGA733 (kindly provided by Dr William Wunner, Wistar Institute, Philadelphia, PA, USA) or total soluble protein extract (TSP) from non-transgenic wild-type plants. Blood samples were collected by retro-orbital bleeding before experiment and 10 days after the second immunization; 10 days after the third immunization, mice were sacriWced and bled by cardiac puncture. Sera were analyzed by ELISA and Western blotting. ELISA for bGA733 (1 g/ml in PBS) was performed essentially as described [23] . Antigen-speciWc antibodies were detected using goat anti-mouse IgG (BD Biosciences, San Jose, CA, USA), goat anti-mouse IgG2b and IgG3 (Bethyl Labs, Montgomery, TX, USA) and rat anti-mouse IgG1 and IgG2a (BD Biosciences). Results are presented as mean § SD.
Inhibition of tumor growth in vivo
Human colorectal carcinoma cells SW948 were maintained according to the supplier's instructions (ATCC) in DMEM supplemented with 10% FBS. Six-to-8-week-old BALB/c nu/nu mice (5 per group) (Charles River Laboratories, Wilmington, MA, USA) were inoculated s.c. with 10 6 cells on the back of the neck followed immediately by four i.p. injections at 3-day intervals with 100 l of serum from pGA733 or bGA733 immunized BALB/c mice for a total of 400 l during 7 days. Control groups were injected with 100 l of TSP serum or 100 g of mAb CO17-1A (Centocor, Horsham, PA, USA) using the same regimen. Tumor growth was recorded at 10, 15, 17, 19, 22, 24, 26, 29, 31, 35 and 38 days after initial injection and calculated based on the three major diameters measured with graduated calipers. At the end of the experiment, mice were euthanized by CO 2 inhalation in accordance with the institutional guidelines for animal welfare.
Results
Production and puriWcation of pGA733 (EpCAM)
cDNA of the extracellular domain of antigen GA733 (aa 24-264) was inserted into the pBIV-1.3Tag vector as a translational fusion with the ER signal peptide; c-myc and His 6 tag epitopes and the ER retention signal KDEL (Plant Research International) were attached to the GA733 C-terminus. The antigen expression cassette containing promoter and termination signal was placed in the pBINPlus binary vector, yielding the construct pRB74 (Fig. 1a) . EpCAM coding sequence (except ER signal peptide) was subcloned into the magnICON Icon Genetics' plasmid pICH115999 (Fig. 1a) and used for transient expression of pGA733 [11, 13, 18] .
The magnifection technique provided a robust and rapid way to express recombinant pGA733 transiently in a large biomass plant, such as Swiss chard (Fig. 1b, left) . The recombinant protein was readily detected by Western blotting at 7-9 days, post-infection in transfected leaf tissues (Fig. 1b, right) .
Several stably transformed transgenic tobacco lines selected based on kanamycin resistance (Fig. 1c, left) showed detectable amounts of pGA733 in leaf extracts on Western blot analysis (Fig. 1c, right) . Quantitative ELISA indicated a variable level of recombinant antigen expression with up to 10 mg/kg of fresh leaves (not shown). The transgenic line with the highest detectable antigen amount was self-crossed to obtain a homozygous line.
The GA733 protein remained stable in fresh and lyophilized plant tissues at ambient temperatures or at 4°C and was used to obtain standardized samples at purity suitable for immunization (Fig. 1d) . Plant-derived antigen was puriWed from tobacco and Swiss chard plants by single step antigen-speciWc immunoaYnity chromatography and/or by two-step aYnity tag-speciWc technique, yielding »5 mg of pGA733 from 1 kg of fresh leaf tissue as veriWed by SDS-PAGE (Fig. 1d, left) and quantitative ELISA. Equal amounts of plant and baculovirus produced GA733, as determined by protein assay, produced bands of similar intensity on coomassie gel and western blot and the same OD in quantitative ELISA with monoclonal antibodies against GA733. PuriWed product resolved as a double-band (both »30 kDa) with a few additional minor bands conWrmed to be subproducts of pGA733 by immunostaining analysis (right). The purity of plant-derived antigen as visualized on SDS-PAGE is »60% (left). Note that migration of the plant-derived protein was slower than that of bGA733 (Fig. 1d) , possibly reXecting the presence of the cmyc and His 6 tags and the KDEL peptide.
Immune response of mice injected with pGA733
All mice injected with pGA733 or bGA733 antigen mounted a strong GA733-speciWc serum antibody response, with comparable titers after either immunization as tested in ELISA against plant-and baculovirus-derived antigen (Fig. 2a) . As expected, both IgG1 and IgG2a/b subclasses were present in the sera, with slight predominance of IgG1 (Fig. 2b) . Western blotting conWrmed the serum speciWcity of anti-GA733 antibodies in mice immunized with bGA733 or pGA733 (Fig. 2c) .
Suppression of tumor growth in mice by plant-derived vaccine
In nude mice xenografted with SW948 colorectal cancer cells and treated with plant TSP serum, the Wrst signs of tumor appeared 10 days after injection; thereafter, tumors grew rapidly, averaging 1,357 mm 3 by day 38 (Fig. 3) . The Wrst signs of tumor appeared by day 15 in mice treated with pGA733 and bGA733 sera and by day 22 in mice treated with mAb CO17-1A (Fig. 3a) . In bGA733-treated group, all mice developed tumors, although development was signiWcantly delayed in two mice. In the mAb CO17-1A treated group, two mice remained tumor-free for the 38-day observation period. At 38 days, mean tumor volumes of both pGA733 and bGA733-treated mice were signiWcantly lower than that of the TSP control group (P < 0.0001) (Fig. 3a, b) . One mouse in pGA733 group remained tumor-free throughout the 38-day observation period. In control plant TSP sera-treated group, all mice developed tumors (Fig. 3b, bottom) .
Discussion
Several TAAs have been identiWed and their immune interactions in patients have been well characterized. In numerous cases, immune approaches to the treatment of cancer have entered the clinical stage [6, 21] . The EpCAM TAA, which has been studied for more than 20 years, is one of the best-described candidates for active immunotherapy of colorectal cancer [20] .
In the last 2 decades, the use of plants for production of a range of diVerent therapeutics has been explored [9, 12, 16, 17] . Our recent comparison of the immune response induced by GA733 produced in baculovirus-infected insect Soluble pGA733 was detected at 7, 8 and 9 days post inoculation (dpi) by Western blotting with antigen-speciWc mAb in total soluble protein (TSP) extracts (right). c Stably transformed tobacco plants (left) and Western blotting (right) of total protein extract from this plants probed with murine mAb AB733. Positive control (+) is the bacteria-expressed GA733 antigen; protein extract from non-transgenic wild-type (wt) tobacco served as a negative control. d SDS-PAGE and Western blotting (at 1:1000 dilution) of soluble pGA733 aYnity-puriWed from plant leaf tissues compared with puriWed bGA733. Numbers on the left indicate molecular size (kDa) cell culture versus GA733 produced in planta using a viral vector [26] revealed a similar antibody response to both antigens in mice, with similar tumor cell speciWcity in in vitro assay. However, the low expression level in this prevented comparison of the anti-cancer activity of the mouse in vivo.
In this study, we used modern plant production schemes [5, 13] to eYciently express the EpCAM TAA. High-yield production was achieved using the "ImpactVector system", which is using the strong RbcS1 promoter from Chrysanthemum and allows direction of antigen expression into speciWc plant cell compartments. Fusion of c-myc and His 6 tags, as well as the ER retention signals KDEL to the C-terminus of GA733 facilitated detection and puriWcation of the antigen. Furthermore, using this expression cassette, we produced considerable amounts of pGA733-expressing leaf biomass using rapid and robust magniWcation of the vegetable plant Swiss chard. Recombinant antigen was expressed at levels of 5-10 mg/kg of fresh leaf material.
The recombinant pGA733 was readily extracted from the pooled leaf material in soluble form. Transgenic T 0 tobacco plants with the highest expression level were processed in a one-step, immunoaYnity-based puriWcation procedure that resulted in »50% recovery of recombinant antigen from plant tissue (»5 mg/kg). Although transient expression and double-step puriWcation was even more eYcient, stably transformed low-alkaloid tobacco appears to be more economically feasible.
The immune response to pGA733 appeared to be the same or only slightlhy weaker than that of an equal dose of bGA733 in BALB/c mice. It seems unlikely that diVerential reactivity, e.g., due to diVerent glycosylation patterns in pGA733 and bGA733, underlies this observation, since similar results were obtained in ELISA with either antigen. Moreover, Western blot analysis of mouse sera against pGA733 and bGA733 at 1:10,000 dilutions revealed similar patterns, indicating high purity of both antigens. Reactivity of anti-pGA733 sera appeared to be in this case a bit higher with pGA733 compared to bGA733 (Fig. 2c) . In earlier analyses of the immunological properties of pGA733 using QS21 as adjuvant, we observed a predominantly IgG1 response [26] , whereas in the present study we detected a higher percentage of IgG2a/b antibodies in sera of mice immunized with either pGA733 or bGA733, although IgG1 antibodies remained a prominent subclass (Fig. 2b) . This is likely due to the use of Freund's adjuvant.
Sera from mice immunized with pGA733, bGA733 or mAb CO17-1A demonstrated signiWcant inhibition of tumor growth in comparison to TSP control sera in xenografted nude mice. There were no signiWcant diVerences between sera from mice immunized with pGA733 or bGA733 in tumor growth inhibition in vivo. The mAb CO17-1A sera had some advantage over pGA733 and bGA733 sera during the early period (days [15] [16] [17] [18] [19] but the diVerence became insigniWcant later on (days 22-38) (Fig. 3a) .
The possibility that pre-assembled antigen-antibody immune complexes might have superior immunogenicity [3] awaits analysis using plant-derived mAb CO17-1A [15] and plant-derived EpCAM antigen.
Our data clearly demonstrate that pGA733-generated sera display comparable in vitro and in vivo activity to the sera generated against the bGA733 antigen and can eYciently inhibit tumor growth in vivo. This work points to the promise of transgenic plants as an excellent source of anti-cancer vaccines, particularly in the case of this attractive target-EpCAM antigen, which is known to be immunogenic in humans [24] . 
